| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY | 2021-03-31 FY |
|---|---|---|---|---|---|---|
| Revenue | $1.46B | $1.20B | $1.00B | $787.59M | $619.08M | $129.20M |
| Cost of Revenue | – | – | – | – | – | – |
| Gross Profit | – | – | – | – | – | – |
| Operating Expenses | $1.28B | $1.13B | $976.71M | – | – | – |
| R&D | – | – | – | – | – | – |
| SG&A | $94.52M | $82.50M | $85.43M | $89.07M | $64.56M | – |
| Operating Income | – | $66.42M | $10.41M | -$67.57M | -$10.07M | -$5.10M |
| Interest Expense | – | – | – | – | – | – |
| Tax Expense | -$10.04M | $15.38M | $16.59M | $7.02M | $6.75M | – |
| Net Income | $149.22M | $78.30M | $28.18M | $32.08M | -$46.36M | -$6.85M |
| EPS (basic) | – | – | – | 0.3900 | -0.5600 | – |
| EPS (diluted) | – | – | – | – | -0.5600 | – |
| Shares (diluted) | – | – | – | – | $82.33M | – |